Literature DB >> 10684907

Hypothalamic-pituitary-adrenal dysfunction in Apoe(-/-) mice: possible role in behavioral and metabolic alterations.

J Raber1, S F Akana, S Bhatnagar, M F Dallman, D Wong, L Mucke.   

Abstract

Several neurological diseases are frequently accompanied by dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. The HPA axis regulates the secretion of glucocorticoids (GCs), which play important roles in diverse brain functions, including cognition, emotion, and feeding. Under physiological conditions, GCs are adaptive and beneficial; however, prolonged elevations in GC levels may contribute to neurodegeneration and brain dysfunction. In the current study, we demonstrate that apolipoprotein E (apoE) deficiency results in age-dependent dysregulation of the HPA axis through a mechanism affecting primarily the adrenal gland. Apoe(-/-) mice, which develop neurodegenerative alterations as they age, had an age-dependent increase in basal adrenal corticosterone content and abnormally increased plasma corticosterone levels after restraint stress, whereas their plasma and pituitary adrenocorticotropin levels were either unchanged or lower than those in controls. HPA axis dysregulation was associated with behavioral and metabolic alterations. When anxiety levels were assessed in the elevated plus maze, Apoe(-/-) mice showed more anxiety than wild-type controls. Apoe(-/-) mice also showed reduced activity in the open field. Finally, Apoe(-/-) mice showed age-dependent increases in food and water intake, stomach and body weights, and decreases in brown and white adipose tissues. These results support a key role for apoE in the tonic inhibition of steroidogenesis and HPA axis activity and have important implications for the behavioral analysis of Apoe(-/-) mice.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10684907      PMCID: PMC6772921     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  59 in total

1.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells.

Authors:  J A Piedrahita; S H Zhang; J R Hagaman; P M Oliver; N Maeda
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

2.  M1 muscarinic agonist treatment reverses cognitive and cholinergic impairments of apolipoprotein E-deficient mice.

Authors:  A Fisher; R Brandeis; S Chapman; Z Pittel; D M Michaelson
Journal:  J Neurochem       Date:  1998-05       Impact factor: 5.372

3.  Corticotropin-releasing factor and behavior.

Authors:  G F Koob; F E Bloom
Journal:  Fed Proc       Date:  1985-01

Review 4.  Corticosteroids and the control of function in the hypothalamo-pituitary-adrenal (HPA) axis.

Authors:  M F Dallman; S F Akana; N Levin; C D Walker; M J Bradbury; S Suemaru; K S Scribner
Journal:  Ann N Y Acad Sci       Date:  1994-11-30       Impact factor: 5.691

Review 5.  The acute effects of corticosteroids on cognition: integration of animal and human model studies.

Authors:  S J Lupien; B S McEwen
Journal:  Brain Res Brain Res Rev       Date:  1997-06

Review 6.  Human apolipoprotein E: the Alzheimer's disease connection.

Authors:  K H Weisgraber; R W Mahley
Journal:  FASEB J       Date:  1996-11       Impact factor: 5.191

7.  Hippocampal mineralocorticoid, but not glucocorticoid, receptors modulate anxiety-like behavior in rats.

Authors:  J W Smythe; D Murphy; C Timothy; B Costall
Journal:  Pharmacol Biochem Behav       Date:  1997-03       Impact factor: 3.533

8.  Neurosteroids in rat sciatic nerves and Schwann cells.

Authors:  Y Akwa; M Schumacher; I Jung-Testas; E E Baulieu
Journal:  C R Acad Sci III       Date:  1993

9.  Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells.

Authors:  A S Plump; J D Smith; T Hayek; K Aalto-Setälä; A Walsh; J G Verstuyft; E M Rubin; J L Breslow
Journal:  Cell       Date:  1992-10-16       Impact factor: 41.582

10.  Intra-amygdala injections of corticotropin releasing factor facilitate inhibitory avoidance learning and reduce exploratory behavior in rats.

Authors:  K C Liang; E H Lee
Journal:  Psychopharmacology (Berl)       Date:  1988       Impact factor: 4.530

View more
  33 in total

1.  Interactions between life stress factors and carrying the APOE4 allele adversely impact self-reported health in old adults.

Authors:  Yi Zeng; Claude L Hughes; Megan A Lewis; Jianxin Li; Fengyu Zhang
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-07-18       Impact factor: 6.053

2.  Association of microtubule associated protein-2, synaptophysin, and apolipoprotein E mRNA and protein levels with cognition and anxiety levels in aged female rhesus macaques.

Authors:  Gwendolen E Haley; Dominique H Eghlidi; Steven G Kohama; Henryk F Urbanski; Jacob Raber
Journal:  Behav Brain Res       Date:  2012-03-28       Impact factor: 3.332

3.  Genotype differences in anxiety and fear learning and memory of WT and ApoE4 mice associated with enhanced generation of hippocampal reactive oxygen species.

Authors:  Laura E Villasana; Sydney Weber; Tunde Akinyeke; Jacob Raber
Journal:  J Neurochem       Date:  2016-08-19       Impact factor: 5.372

4.  Acute pharmacological modulation of mGluR8 reduces measures of anxiety.

Authors:  Robert M Duvoisin; Tim Pfankuch; Julie M Wilson; Julie Grabell; Vijay Chhajlani; Dean G Brown; Edwin Johnson; Jacob Raber
Journal:  Behav Brain Res       Date:  2010-04-10       Impact factor: 3.332

5.  ApoE2 Exaggerates PTSD-Related Behavioral, Cognitive, and Neuroendocrine Alterations.

Authors:  Lance A Johnson; Damian G Zuloaga; Erin Bidiman; Tessa Marzulla; Sydney Weber; Helane Wahbeh; Jacob Raber
Journal:  Neuropsychopharmacology       Date:  2015-05-10       Impact factor: 7.853

6.  Acetylcholine receptor and behavioral deficits in mice lacking apolipoprotein E.

Authors:  Jessica A Siegel; Theodore S Benice; Peter Van Meer; Byung S Park; Jacob Raber
Journal:  Neurobiol Aging       Date:  2009-01-28       Impact factor: 4.673

7.  Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice.

Authors:  Faith M Harris; Walter J Brecht; Qin Xu; Ina Tesseur; Lisa Kekonius; Tony Wyss-Coray; Jo Dee Fish; Eliezer Masliah; Paul C Hopkins; Kimberly Scearce-Levie; Karl H Weisgraber; Lennart Mucke; Robert W Mahley; Yadong Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-25       Impact factor: 11.205

8.  Diet and age interactions with regards to cholesterol regulation and brain pathogenesis.

Authors:  Romina M Uranga; Jeffrey N Keller
Journal:  Curr Gerontol Geriatr Res       Date:  2010-04-11

9.  Behavioral phenotype of pre-proenkephalin-deficient mice on diverse congenic backgrounds.

Authors:  Andras Bilkei-Gorzo; Ildiko Racz; Kerstin Michel; Anne Zimmer; Dietrich Klingmüller; Andreas Zimmer
Journal:  Psychopharmacology (Berl)       Date:  2004-06-09       Impact factor: 4.530

10.  Androgens protect against apolipoprotein E4-induced cognitive deficits.

Authors:  Jacob Raber; Gerold Bongers; Anthony LeFevour; Manuel Buttini; Lennart Mucke
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.